Related Experiment Video
Updated: May 8, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Fulminant hepatitis due to human adenovirus
Human adenovirus (HAdV) hepatitis is a severe liver disease in immunocompromised patients. Early diagnosis via liver biopsy and reduced immunosuppression can improve survival rates.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Human adenovirus (HAdV) hepatitis is a rare but serious condition.
- It primarily affects immunocompromised individuals, including transplant recipients and those undergoing chemotherapy.
Observation:
- A literature review identified 89 cases of HAdV hepatitis.
- Fever was the most common symptom, and hypodense lesions were noted on CT scans.
- Diagnosis was confirmed by liver biopsy or autopsy.
Findings:
- The majority of cases (90%) occurred within six months post-transplantation.
- Only 27% of patients survived, with improved outcomes seen after reducing immunosuppression or liver re-transplantation.
- Cidofovir and intravenous immunoglobulin showed some benefit in survivors.
Implications:
- HAdV hepatitis can lead to fulminant liver failure in immunocompromised hosts.
- Prompt diagnosis through liver biopsy is crucial.
- Management strategies include reducing immunosuppression and considering liver transplantation.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10:22Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Influenza
Cytomegalovirus Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology